Who are Aloe Therapeutics's investors?

Aloe Therapeutics's investors include The Innovation Space.

How much funding has Aloe Therapeutics raised?

Aloe Therapeutics has disclosed $100K raised across 1 round.

Where is Aloe Therapeutics headquartered?

Aloe Therapeutics is headquartered in Darnestown, US.

Aloe Therapeutics

Darnestown, US · Founded 2020 · 1 known investors

Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at a tumor site during biopsy or resection surgery to activate the immune system and make patients more responsive to checkpoint immunotherapy. It targets advanced solid tumors across multiple tumor types and disease stages.

Biotech Healthtech

Founders & leadership

Martha SklavosinNamed on SEC filing

Investors · 1

The Innovation SpaceWilmington · $200K

Reported raises · per SEC filings

Form D private placements

$100K disclosed across 1 round · 2024

▶$100KraisedMar 2024 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Martha SklavosExecutive Officer, Director

Offering amount: $100K
Amount sold: $100K
First sale: Mar 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Applied Therapeutics17 shared keywordsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.

Solu13 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.

Bioworld11 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Aloe Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Aloe Therapeutics do?: Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at a tumor site during biopsy or resection surgery to activate the immune system and make patients more responsive to checkpoint immunotherapy. It targets advanced solid tumors across multiple tumor types and disease stages.
Who are Aloe Therapeutics's investors?: Aloe Therapeutics's investors include The Innovation Space.
How much funding has Aloe Therapeutics raised?: Aloe Therapeutics has disclosed $100K raised across 1 round.
Where is Aloe Therapeutics headquartered?: Aloe Therapeutics is headquartered in Darnestown, US.